| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |